全文获取类型
收费全文 | 3020篇 |
免费 | 200篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 111篇 |
妇产科学 | 63篇 |
基础医学 | 340篇 |
口腔科学 | 59篇 |
临床医学 | 282篇 |
内科学 | 640篇 |
皮肤病学 | 31篇 |
神经病学 | 187篇 |
特种医学 | 377篇 |
外国民族医学 | 1篇 |
外科学 | 479篇 |
综合类 | 39篇 |
预防医学 | 155篇 |
眼科学 | 62篇 |
药学 | 158篇 |
中国医学 | 1篇 |
肿瘤学 | 240篇 |
出版年
2022年 | 14篇 |
2021年 | 46篇 |
2020年 | 37篇 |
2019年 | 40篇 |
2018年 | 64篇 |
2017年 | 56篇 |
2016年 | 69篇 |
2015年 | 60篇 |
2014年 | 80篇 |
2013年 | 101篇 |
2012年 | 130篇 |
2011年 | 132篇 |
2010年 | 83篇 |
2009年 | 85篇 |
2008年 | 103篇 |
2007年 | 109篇 |
2006年 | 120篇 |
2005年 | 124篇 |
2004年 | 109篇 |
2003年 | 119篇 |
2002年 | 98篇 |
2001年 | 93篇 |
2000年 | 87篇 |
1999年 | 89篇 |
1998年 | 79篇 |
1997年 | 75篇 |
1996年 | 59篇 |
1995年 | 38篇 |
1994年 | 55篇 |
1993年 | 32篇 |
1992年 | 53篇 |
1991年 | 58篇 |
1990年 | 61篇 |
1989年 | 73篇 |
1988年 | 52篇 |
1987年 | 52篇 |
1986年 | 73篇 |
1985年 | 48篇 |
1984年 | 51篇 |
1983年 | 27篇 |
1982年 | 26篇 |
1981年 | 40篇 |
1980年 | 17篇 |
1979年 | 23篇 |
1978年 | 29篇 |
1977年 | 20篇 |
1976年 | 24篇 |
1975年 | 14篇 |
1972年 | 12篇 |
1966年 | 13篇 |
排序方式: 共有3238条查询结果,搜索用时 15 毫秒
91.
Black HR Elliott WJ Neaton JD Grandits G Grambsch P Grimm RH Hansson L Lacoucière Y Muller J Sleight P Weber MA White WB Williams G Wittes J Zanchetti A Fakouhi TD Anders RJ 《Hypertension》2001,37(1):12-18
-Blood pressure (BP) control rates around the world are suboptimal. Part 2 of the National Health and Nutrition Educational Survey (NHANES) III indicates that only 27.4% of hypertensive Americans aged 18 to 74 years have a BP of <140/90 mm Hg. We wanted to assess BP control during the first 2 years and to describe the baseline characteristics of patients enrolled in the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Study, an international clinical trial that compares outcomes in hypertensive patients randomized to initial treatment with either controlled-onset extended-release verapamil or the investigator's choice of atenolol or hydrochlorothiazide. At randomization, BP was <140/90 mm Hg in only 20.3% of the 16 602 subjects (average+/-SD age 65.6+/-7.4 years; 56% women, 84% white/7% black/7% Hispanic). The average BP at enrollment was 148/85 mm Hg for patients taking BP medications (n=13 879) and 161/94 mm Hg for previously untreated patients (n=2723). After medication titration, with a transtelephonic computer that recommended an increase in the dose or number of antihypertensive agents whenever the BP was 140/90 mm Hg, 84.8% of the subjects attained the goal BP. During 2 years of treatment, BP control was maintained in 67% to 69% of the subjects (69% to 71% for systolic BP of <140 mm Hg and 90% for diastolic BP of <90 mm Hg). These data suggest that the control of systolic BP is more difficult than the control of diastolic BP. The US national goal of having 50% of hypertensives with a BP of <140/90 mm Hg may be achievable if a forced titration strategy is used. Interested investigators, free care and medications, and well-educated subjects may make the attainment of such a goal easier in the CONVINCE study than in the general population. 相似文献
92.
93.
Anne Kathrine Toxvig Markus Wehland Daniela Grimm Manfred Infanger Marcus Krüger 《Basic & clinical pharmacology & toxicology》2019,125(3):202-214
Current treatment of pulmonary arterial hypertension (PAH) targets three signalling pathways: the nitric oxide (NO) pathway, the endothelin pathway and the prostacyclin pathway. Riociguat is a soluble guanylate cyclase stimulator, acting via the NO pathway in a new way: unlike other common drugs targeting this pathway (eg tadalafil and sildenafil), riociguat acts independently of endogenous NO. This MiniReview focuses on PAH treatment with riociguat and on its advantages and disadvantages compared with other drugs targeting the NO pathway. In the PATENT‐1 trial (NCT00810693), riociguat improved significantly the 6‐minute walking distance in patients suffering from PAH, with a mean difference (MD) of 36 m compared with a placebo group. The results are comparable to those found for its competitors tadalafil (MD of 33 m) and sildenafil (MD of 50 m) in the PHIRST‐1 trial (NCT00125918) and the SUPER‐1 trial (NCT00644605). No obvious advantages were found regarding pharmacokinetic features and adverse events. In the RESPITE study (NCT02007629), patients with PAH with insufficient response to treatment with tadalafil or sildenafil were switched to riociguat. These results indicate that riociguat might be superior regarding efficacy to PDE‐5 inhibitors in a patient group, where endogenous NO production might be insufficient. This finding was further examined in the REPLACE study (NCT02891850). Moreover, riociguat has shown promising anti‐proliferative, anti‐inflammatory and anti‐fibrotic effects in animal models. Further investigations are needed to determine whether this applies also to human beings. Taken together, riociguat induces vasodilation of the pulmonary arteries and leads to an improvement in the ability to carry out physical activity. 相似文献
94.
Objective:To investigate the wound healing properly of Napoleona vogelii leaf extract in folkloric medicine.Methods:Roth sexes of adult albino rats(n=25) were used in this study and another group(n=30) were subjected to acute toxicity test(LD_(50)) of the plant extract.For the LD_(50),three randomized groups of 5 rats were first treated with 10,100,1 000 mg/kg body weight(bw),orally.This w as followed by a second treatment of 1500,3000,and 5 000 mg/kg bw of the leaf extract with continual monitoring of the animals for mortality or non-mortality.Incision wounds(1.3cm) were created on the skin of five groups of 5 rals using surgical blade under anesthesia.The first group was topically treated with petroleum jelly alone,group 2 was topically applied 400 mg/mL w/v of the reference drug,Neobaein,while group 3-5 were topically treated with 5-50 mg/mL w/v of the plant extract,respectively.Results:The percentage yield of the extract was 49.80%w/w dry matter.The phytochemical analysis revealed several bioactive constituents including glycosides,tannins,alkaloids,perpenoids.saponins,steroids,proteins,and carbohydrates.The LD_(50) was beyond our experimental limit and was not determined.Increased concentrations(5,20,and 50mg/mL w/v) of the extract had significant(ANOVA,P0.05) healing effect on the incision wounds giving rise to 125%-140% while treatmentawith Neobacin resulted in 150% healing effect on the third treatment regimen compared to the control(100%).Conclusions:These data indicate that Napoleona vogelii leaf extract contains potent bioactive compounds containing wound healing activity,substantiating its use as a wound healer in folkloric medicine. 相似文献
95.
96.
Anne Weigand Aline Richtermeier Melanie Feeser Jia Shen Guo Benny B. Briesemeister Simone Grimm Malek Bajbouj 《Brain stimulation》2013,6(6):905-912
BackgroundA growing body of findings illustrates the importance of state-dependency in studies using brain stimulation.ObjectiveWe aimed to investigate the effects of tDCS priming followed by rTMS applied over the right dorsolateral prefrontal cortex (DLPFC) on emotional working memory.MethodsIn a randomized single-blind within-subjects design, participants performed an emotional 3-back task at baseline and after tDCS priming (anodal, cathodal) and subsequent low-frequency rTMS (active, sham) of the right DLPFC. Stimuli consisted of words related to the distinct emotion categories fear and anger as well as neutral words.ResultsTask accuracy increased for fear-related words and decreased for neutral words across stimulation conditions. No general state-dependent effects of prefrontal rTMS on working memory were found. We further showed a detrimental effect of negative emotional content on working memory performance.ConclusionsOur findings support a hemispheric lateralization of emotion processing by demonstrating that the withdrawal-related emotion fear is associated with the right DLPFC and contribute to clarifying the interaction between working memory and emotion. 相似文献
97.
S Erk A Meyer-Lindenberg P Schmierer O Grimm H Tost T Mühleisen M Mattheisen N Seiferth S Cichon M Rietschel M M N?then A Heinz H Walter 《Translational psychiatry》2013,3(7):e287
In a large brain-imaging study, a multinational consortium has recently identified a common genetic variation in rs7294919 being associated with hippocampal volume. Here, we explored whether this quantitative trait locus also affects hippocampal function using a previously established reliable neuroimaging paradigm. We observed a significant effect of rs7294919 variation in the right hippocampus showing that hippocampal activation increased with the number of risk alleles. Furthermore, the risk allele was associated with decreased performance in a verbal learning and memory task. By showing that this single-nucleotide polymorphism also relates to behavioral difference and underlying brain activation in memory, our findings support the idea that rs7294919 may affect the individual capacity to resist disease in terms of diminishing or boosting hippocampal resources. 相似文献
98.
Martin Grimm Michael Krimmel Dorothea Alexander Adelheid Munz Susanne Kluba Constanze Keutel Juergen Hoffmann Joachim Polligkeit Siegmar Reinert Sebastian Hoefert 《Clinical oral investigations》2013,17(3):949-955
Objectives
Overexpression of the histamine H1 receptor (H1R) has been described in a variety of tumor models, but experience in oral squamous cell carcinomas (OSCC) is not available. Current adjuvant treatment options for OSCC can be improved by the identification of new targets of therapy. Herein, we evaluated H1R expression in a large patient cohort of OSCC.Materials and methods
H1R immunoexpression was evaluated in 191 cases of OSCC and two OSCC cell lines BICR56 and BICR3. Scanned images were digitally analyzed using ImageJ and the immunomembrane plug-in. The combined score of computer-assisted semiquantitative analysis was correlated with manually counted percentages of tumor cells by Kendall’s tau (т) correlation coefficient. Disease-free survival times were estimated using the Kaplan–Meier method and were compared by using the log-rank test. Multivariate analyses were performed using the Cox proportional hazards model.Results
H1R was rarely expressed in OSCC but significantly related with advanced tumor stages (n?=?21/191, mean expression 63.5 % of cancer cells in positive tumor samples, 95 % confidence interval of the mean 53.5 to 73.6 %, p?=?0.006). Following univariate analysis, patients with H1R expression showed a significant poorer prognosis (p?=?0.0004). Multivariate analysis revealed H1R expression as an independent prognostic factor (p?=?0.0164). Expression of H1R in cancer cell lines was confirmed by specific staining of OSCC cell lines BICR56 and BICR3.Conclusion
This is the first study focusing on H1R expression showing a significant poorer DFS rate in the H1R+ patient cohort. Based on these data, H1R activation may promote carcinogenesis in OSCC.Clinical relevance
Investigation of H1R regulation and its antagonists shows a clear rationale for future supportive anticancer therapies in OSCCs. 相似文献99.